Detail Diabetes Care vol. 38 no. 03 (Mar. 2015) Bibliografi Topik: Diabetes Bahasa: (EN )    ISSN: 0149-5992    Year:: 2015    Bulan: 03    Edisi: Mar 2015     Penerbit: American Diabetes Association Jenis: Journal - ilmiah internasional [Lihat daftar eksemplar jurnal Diabetes Care] Ketersediaan Perpustakaan FK Nomor Panggil: D05.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada     Lihat Detail Induk Artikel dalam koleksi ini Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study , halaman 355-364 Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial , halaman 365-372 Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?, halaman 373-375 Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes, halaman 394-402 Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study , halaman 412-419 Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes, halaman 429-430 Trends in Diabetes Incidence: The Framingham Heart Study, halaman 482-487 Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin , halaman 376-383 Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin , halaman 384-393 Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes , halaman 403-411 Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension, halaman 420-428 Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy , halaman 431-438 PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial , halaman 439-444 Mild Gestational Diabetes Mellitus and Long-Term Child Health, halaman 445-452 Life Years Lost and Lifetime Health Care Expenditures Associated With Diabetes in the U.S., National Health Interview Survey, 1997–2000 , halaman 460-468 How Do People With Diabetes Describe Their Experiences in Primary Care? Evidence From 85,760 Patients With Self-reported Diabetes From the English General Practice Patient Survey , halaman 469-475 Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes, halaman 476-481 Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals, halaman 488-494 The Risk of Colorectal Cancer in Patients With Type 2 Diabetes: Associations With Treatment Stage and Obesity, halaman 495-502 Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes, halaman 503-512 Tyrosine Phosphatase–Related Islet Antigen 2(256–760) Autoantibodies, the Only Marker of Islet Autoimmunity That Increases by Increasing the Degree of BMI in Obese Subjects With Type 2 Diabetes , halaman 513-520 Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes, halaman 521-528 Sleep Duration and Risk of Type 2 Diabetes: A Meta-analysis of Prospective Studies, halaman 529-537  Edit Artikel Lihat Sejarah Pengadaan  Konversi Metadata   Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved